BioSpace News Archive

ProSomnus Sleep Technologies (“ProSomnus”), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of a peer-reviewed study published by the Journal of Clinical Sleep Medicine (JCSM), which found that ProSomnus’s precision Oral Appliance Therapy (OAT) devices successfully treated most patients’ OSA.

Cullinan Oncology, Inc. a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, announced that its management team will participate in the following virtual conferences in April.

Rhaeos, Inc., a private medical device company focused on the care of patients with chronic medical conditions, announces the issuance of U.S. patents 11,160,458 and 11,259,754 covering flexible, wearable sensors for non-invasive monitoring of subdermal fluid flow, including cerebrospinal fluid in hydrocephalus shunts and blood flow in both capillaries and large vessels.

Curis, Inc. today announced that James Dentzer , President and Chief Executive Officer of Curis, will present a company overview at the 21st Annual Needham Virtual Healthcare Conference.

Affini-T Therapeutics, Inc, a biotechnology company unlocking the power of T cells against oncogenic driver mutations, announced the appointments of Michael Varney, Ph.D., and Daniel Faga to its board of directors.

NewAmsterdam Pharma (NAP) today announced dose administration for the first patient in ROSE2, the Company’s Phase 2 trial of obicetrapib, a novel cholesteryl ester transfer protein (CETP) inhibitor.

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines, called prescription digital therapeutics, announced management will participate in the following upcoming virtual investor conferences in April 2022.

Catamaran Bio , Inc. today announced the appointment of Frank Lee as Chair of its Board of Directors.

Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company, announced updated financial guidance for the full year 2022 to include the expected impact of the BioDelivery Sciences International Inc. acquisition.

MiMedx Group, Inc., a transformational placental biologics company, announced it will sponsor a lunch symposium at the Symposium on Advanced Wound Care Spring on April 6-10 in Phoenix, Arizona.